These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Imaging as a means of studying chemotherapy-related cognitive impairment. Raffa RB Adv Exp Med Biol; 2010; 678():70-6. PubMed ID: 20738008 [TBL] [Abstract][Full Text] [Related]
3. Patient's perspective. Raffa RB; Martin KJ Adv Exp Med Biol; 2010; 678():11-2. PubMed ID: 20738000 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-related visual system toxicity. Raffa RB Adv Exp Med Biol; 2010; 678():113-8. PubMed ID: 20738012 [TBL] [Abstract][Full Text] [Related]
6. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Shilling V; Jenkins V; Trapala IS Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398 [TBL] [Abstract][Full Text] [Related]
7. The economic burden. Wertheimer AI Adv Exp Med Biol; 2010; 678():33-6. PubMed ID: 20738005 [TBL] [Abstract][Full Text] [Related]
8. Short introduction and history. Raffa RB Adv Exp Med Biol; 2010; 678():1-10. PubMed ID: 20737999 [TBL] [Abstract][Full Text] [Related]
9. [An overview of the research of cancer-related cognitive impairment]. Ferencz V; S Nagy Z; Tóth M Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098 [TBL] [Abstract][Full Text] [Related]
11. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? Raffa RB; Duong PV; Finney J; Garber DA; Lam LM; Mathew SS; Patel NN; Plaskett KC; Shah M; Jen Weng HF J Clin Pharm Ther; 2006 Apr; 31(2):129-38. PubMed ID: 16635046 [No Abstract] [Full Text] [Related]
12. Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'. Raffa RB; Tallarida RJ J Clin Pharm Ther; 2010 Jun; 35(3):249-55. PubMed ID: 20831527 [TBL] [Abstract][Full Text] [Related]
13. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Aluise CD; Sultana R; Tangpong J; Vore M; St Clair D; Moscow JA; Butterfield DA Adv Exp Med Biol; 2010; 678():147-56. PubMed ID: 20738017 [TBL] [Abstract][Full Text] [Related]
14. Clearing the air: a review of our current understanding of "chemo fog". O'Farrell E; MacKenzie J; Collins B Curr Oncol Rep; 2013 Jun; 15(3):260-9. PubMed ID: 23483375 [TBL] [Abstract][Full Text] [Related]
17. Fighting the fog of "chemo brain." Chemotherapy may keep your cancer at bay but it also may cloud your mind. Duke Med Health News; 2009 Feb; 15(2):8-9. PubMed ID: 19353815 [No Abstract] [Full Text] [Related]
18. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'. Raffa RB J Clin Pharm Ther; 2010 Feb; 35(1):1-9. PubMed ID: 20175809 [TBL] [Abstract][Full Text] [Related]
19. Oncology pharmacist's perspective. Clark-Vetri R Adv Exp Med Biol; 2010; 678():19-20. PubMed ID: 20738002 [TBL] [Abstract][Full Text] [Related]
20. Lost in the fog: understanding "chemo brain". Hafner DL Nursing; 2009 Aug; 39(8):42-5. PubMed ID: 19633502 [No Abstract] [Full Text] [Related] [Next] [New Search]